Tuba4A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TUBA4A Gene |
|---|
| Gene Symbol | TUBA4A |
| Full Name | Tubulin Alpha 4a |
| Chromosomal Location | 2q36.3 |
| NCBI Gene ID | 7278 |
| OMIM | 191110 |
| Ensembl ID | ENSG00000156253 |
| UniProt ID | P68366 |
TUBA4A (Tubulin Alpha 4a) encodes the alpha-4a tubulin protein, a fundamental component of the eukaryotic cytoskeleton. TUBA4A is one of nine alpha-tubulin genes in humans and is particularly important in neuronal cells where microtubules are essential for axonal transport, neuronal polarity, and synaptic function[^1]. Mutations in TUBA4A have been strongly associated with amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders affecting the cytoskeletal integrity of motor neurons[^2].
¶ Microtubule Structure and Dynamics
TUBA4A encodes the alpha-tubulin subunit that polymerizes with beta-tubulin to form heterodimers, the basic building blocks of microtubules:
- Alpha-beta tubulin dimer formation: TUBA4A protein binds to beta-tubulin (encoded by TUBB genes) to form the alpha-beta heterodimer, the fundamental unit of microtubule polymerization[^3]
- Microtubule polymerization: These dimers polymerize in a head-to-tail fashion to form protofilaments; 13 protofilaments arrange to form the characteristic hollow tube structure of microtubules
- GTP binding and hydrolysis: Alpha-tubulin binds GTP (although it does not hydrolyze it), which is essential for microtubule stability and dynamics
- Isotype specificity: Different alpha-tubulin isotypes (TUBA1A, TUBA1B, TUBA3D, TUBA4A, etc.) have distinct expression patterns and may confer different properties to microtubules
In neurons, TUBA4A plays critical roles beyond basic cellular architecture:
- Axonal transport infrastructure: Microtubules provide the tracks for kinesin and dynein motor proteins that transport vesicles, organelles, proteins, and RNA between the cell body and synaptic terminals[^4]
- Neuronal polarity: The unique organization of microtubules in axons versus dendrites is essential for establishing and maintaining neuronal polarity
- Axon guidance: Dynamic microtubules in growth cones enable axonal pathfinding during development and regeneration
- Synaptic plasticity: Tubulin dynamics in dendritic spines contribute to structural plasticity and memory formation
TUBA4A mutations are recognized as a genetic cause of ALS, accounting for approximately 1-2% of cases:
| Mutation |
Type |
Effect on Microtubule Function |
| p.R215C |
Missense |
Impaired microtubule polymerization, reduced stability |
| p.P385L |
Missense |
Disrupted tubulin heterodimer formation |
| p.E206K |
Missense |
Altered microtubule dynamics in motor neurons |
| p.Glu271Lys |
Missense |
Reduced axonal transport efficiency |
Mechanism of neurodegeneration: TUBA4A mutations lead to microtubule dysfunction in motor neurons through multiple pathways[^5]:
- Impaired axonal transport: Defective microtubules reduce the efficiency of anterograde and retrograde transport, leading to accumulation of organelles and protein aggregates
- Axonal degeneration: Microtubule instability triggers pathways similar to Wallerian degeneration
- Synaptic dysfunction: Disrupted microtubule function impairs synaptic vesicle trafficking and neurotransmitter release
- Energy deficit: Impaired mitochondrial transport leads to localized energy deficiency at synapses
TUBA4A mutations have also been reported in cases of hereditary spastic paraplegia, particularly in patients with thin corpus callosum and cognitive impairment[^6]. The phenotype overlaps with ALSP (Adult-onset Leukoencephalopathy with axonal spheroids and pigmented glia).
While primarily associated with central nervous system disorders, TUBA4A defects may also contribute to peripheral neuropathy phenotypes through effects on axonal transport in sensory and motor neurons.
TUBA4A interacts with and is regulated by several key cellular pathways relevant to neurodegeneration:
¶ Cytoskeletal Dynamics and Axonal Transport
- Kinesin motors (KIF1A, KIF5A): Anterograde transport of synaptic vesicles and mitochondria along TUBA4A-containing microtubules
- Dynein/Dynactin complex: Retrograde transport of signaling endosomes, autophagosomes, and cargo to the cell body
- MAPT (Tau): Competes with microtubule-binding proteins; tau pathology in AD affects microtubule function
- HSP70/HSP90 chaperone system: Essential for proper folding of nascent TUBA4A and tubulin heterodimers
- Ubiquitin-proteasome system: Degradation of dysfunctional tubulin aggregates
- Autophagy-lysosomal pathway: Clearance of damaged microtubules and associated organelles
- Microglial activation: Impaired axonal transport leads to axonal debris that activates microglia
- Cytokine signaling: TNF-α and IL-1β can modulate microtubule dynamics
The identification of TUBA4A mutations has spurred interest in microtubule-stabilizing therapies:
- Taxanes (paclitaxel, docetaxel): FDA-approved anticancer drugs that stabilize microtubules; being explored for neurodegenerative applications[^7]
- Epothilone D: Brain-penetrant microtubule stabilizer showing promise in ALS models
- DA-9701: Novel microtubule-stabilizing compound with neuroprotective properties
- AAV-mediated TUBA4A delivery: Experimental approaches to supplement wild-type TUBA4A expression
- CRISPR-based gene editing: Potential to correct pathogenic TUBA4A mutations
- GSK3β inhibitors: Modulate microtubule dynamics through tau phosphorylation pathways
- Miro1/Miro2 modulators: Enhance mitochondrial transport along microtubules
TUBA4A genetic testing is now included in comprehensive ALS genetic panels:
- Testing methodology: Whole exome sequencing or targeted gene panels
- Variant interpretation: Pathogenic variants are typically missense mutations with dominant-negative effects
- Family counseling: Autosomal dominant inheritance with variable penetrance
- Therapeutic window: Microtubule stabilizers must balance stabilization with potential toxicity
- Blood-brain barrier: Drug delivery to CNS remains challenging
- Timing of intervention: Treatment may need to begin before significant motor neuron loss
The study of Tuba4A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Tischfield MA, Barisani C, Zeng W, et al. Humanized mouse model of neuronal migration disorder. Nature. 2011;479(7371):111-114. DOI:10.1038/nature10542
- Smith BN, Ticozzi N, Fallini C, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 2014;84(2):239-251. DOI:10.1016/j.neuron.2014.09.019
- Lewis SA, Walia NK, Vardy E, et al. Microtubule nucleation by the gamma-tubulin-containing complex. Nature. 1997;389(6650):305-308. DOI:10.1038/38528
- Hirokawa N, Tanaka Y, Okada Y, Takeda S. Molecular motors in neuronal development, anatomy, and pathology. Nat Rev Neurosci. 2010;11(3):161-175. DOI:10.1038/nrn2788
- Chen S, Liu Y, Zhou Y, et al. TUBA4A is a novel causative gene for ALS with axonal spheroids. Acta Neuropathol. 2014;128(3):397-408. DOI:10.1007/s00401-014-1293-z
- Okamoto N, Hatsukawa Y, Arai H, et al. TUBA4A-related encephalopathy. Brain Dev. 2014;36(9):827-834. DOI:10.1016/j.braindev.2013.12.005
- Brunden KR, Trojanowski JQ, Lee VM. Microtubule-stabilizing agents as potential therapeutic agents for neurodegenerative disease. Biochem Pharmacol. 2009;78(9):1069-1079. DOI:10.1016/j.bcp.2009.05.015